FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease

Two independent analyses performed in a cohort of mild PD patients replicated key features of the PDRP, confirming that FDG-PET and multivariate classification can provide an objective, sensitive biomarker of disease stage with the potential to detect treatment effects on PD progression.